Where benefit funds sued drug manufacturer for deceptive marketing under the Racketeer Influenced and Corrupt Organizations Act, a complaint should not have been dismissed as untimely at the pleading stage.The 7th U.S. Circuit Court of Appeals reversed a decision by U.S. District Judge Sara L. Ellis.Abbott Laboratories was sued by a collection of multiemployer benefit funds alleging that Abbott and its subdivision AbbVie violated the Racketeer Influenced and Corrupt Organizations Act through efforts to promote the …